A phase II study of concurrent chemo-radiation (CXRT) with irinotecan and carboplatin followed by consolidation docetaxel for stage III non-small cell lung cancer (NSCLC): Initial outcome and toxicity results

被引：0
|
作者：
Biagioli, M. [1 ]
Raez, L. [1 ]
Takita, C. [1 ]
Rocha-Lima, C. [1 ]
Roman, E. [1 ]
Zimmerman, Z. [1 ]
Kar, M. [1 ]
Farfan, N. [1 ]
Markoe, A. [1 ]
机构：
[1] Univ Miami, Sch Med, Miami, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 66卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2006.07.904
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2493
引用
下载
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [21] Long term results of induction carboplatin (CBDCA) and docetaxel (DOC) with concurrent radiation followed by surgery in early-stage non-small cell lung cancer (NSCLC)
    Katakami, Nobuyuki
    Hata, Akito
    Kubota, Mio
    Nishimura, Takashi
    Naya, Reiko
    Seo, Ryutaro
    Hayashi, Michio
    Takahashi, Yutaka
    Ishihara, Kyosuke
    ANNALS OF ONCOLOGY, 2006, 17 : 228 - 228
  • [22] Optimisation of the treatment pathway for stage III non-small cell cancer (NSCLC) patients receiving concurrent chemo-radiation (cCRT)
    Pickles, Rebecca
    Smith, Eleanor
    Turnbull, Helen
    Stamp, Alexander
    Mcdonald, Fiona
    LUNG CANCER, 2022, 165 : S52 - S52
  • [23] Phase II and pharmacokinetic (pk) study of induction docetaxel/cisplatin followed by pulsed docetaxel chemoradiation for stage III non-small cell lung cancer (NSCLC)
    Chen, Y.
    Pandya, K. J.
    Smudzin, T.
    Strychor, S.
    Sidone, B.
    Zamboni, W. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Mature results of a phase II trial on individualised accelerated radiotherapy based on normal tissue constraints in concurrent chemo-radiation for stage III non-small cell lung cancer
    van Baardwijk, Angela
    Reymen, Bart
    Wanders, Stofferinus
    Borger, Jacques
    Ollers, Michel
    Dingemans, Anne-Marie C.
    Bootsma, Gerben
    Geraedts, Wiel
    Pitz, Cordula
    Lunde, Ragnar
    Peters, Frank
    Lambin, Philippe
    De Ruysscher, Dirk
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (15) : 2339 - 2346
  • [25] Phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer (NSCLC): Updated results of an ongoing study.
    Read, WL
    Toles, L
    Romvari, E
    Adkins, D
    McLeod, H
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 707S - 707S
  • [26] Phase II study of carboplatin, irinotecan, and thalidomide in patients with advanced non-small cell lung cancer (NSCLC).
    Miller, AA
    Case, D
    Atkins, J
    Giguere, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 649S - 649S
  • [27] Concurrent chemoradiation with pemetrexed and cisplatin followed by consolidation pemetrexed for patients with unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase I study
    Cardenal, Felipe
    Arnaiz, Ma Dolores
    Moran, Teresa
    Jove, Josep
    Sole, Josep Ma
    Porta, Ruth
    Nadal, Ernest
    Brao, Isabel
    Palmero, Ramon
    Fuentes, Rafael
    Nunez, Inmaculada
    Cassinello, Alejo
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S849 - S849
  • [28] WEEKLY DOCETAXEL AND CARBOPLATIN WITH CONCURRENT RADIATION THERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Tanikawa, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 123 - 123
  • [29] Pilot study of continuous infusion topotecan with concurrent radiation followed by consolidation etoposide platinum and docetaxel for patients with high risk unresectable stage III non-small cell lung cancer (NSCLC)
    Ross, HJ
    Fisher, BK
    Seung, SK
    LUNG CANCER, 2004, 46 : S57 - S57
  • [30] Long-Term Results of a Phase II Trial of Induction Paclitaxel-Carboplatin Followed by Concurrent Radiation Therapy and Weekly Paclitaxel and Consolidation Paclitaxel-Carboplatin in Stage III Non-small Cell Lung Cancer
    Casas, Francesc
    Vinolas, Nuria
    Ferrer, Ferran
    Agusti, Carles
    Sanchez, Marcelo
    Maria Gimferrer, Josep
    Lomena, Francisco
    Campayo, Marc
    Jeremic, Branislav
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 79 - 85
12345